Monk, B. J., Romero, I., O'Malley, D. M., Mena, C. M., Willmott, L., Auranen, A., Slomovitz, B. M., Bergamini, A., Prendergast, E. N., Rouge, T. D. L. M., McCormick, C. C., Braicu, E. I., Backes, F. J., Perez-Fidalgo, J. A., Moore, R. G., Valabrega, G., O'Cearbhaill, R. E., Kim, S., Bains, M., González-Martín, A. (2026). Efficacy prediction for progression-free survival (PFS) and overall survival (OS) by genomic instability score (GIS) cutoffs in patients (pts) with advanced ovarian cancer (aOC): Post hoc results from the phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5565